CTMX - Cytomx Therapeutics, Inc.

CTMX sits in the Biotechnology industry within the Health Care sector, so this activity is best read against the sector's broader insider trend.

Insider Ownership

Role	Insider	Shares	Value	30d
CEO	McCarthy Sean A.	1.08M	$6.93M	-
VP	Belvin Marcia	300.8K	$1.93M	-
CFO	Ogden Christopher	295.3K	$900.7K	-
Other	Chu Yu-Waye	189.4K	$1.22M	-
Other	Carvajal Alejandra	100.0K	-	-

Buys and sells only

10 filings · page 4

Date	Insider	Role	Type	Shares	Price	Value	Chg%	3M	12M
Sep 22, 2023	Belvin Marcia52	SVP, Chief Scientific Officer	Sell	4,119	$1.30	$5,355.94	-2.7%	+10.2%	-7.0%
Sep 22, 2023	Landau Jeffrey B55	Chief Business Officer	Sell	4,119	$1.30	$5,355.94	-5.1%	+10.2%	-7.0%
Sep 22, 2023	McCarthy Sean A.68	CEO	Sell	14,601	$1.30	$18,987.14	-3.3%	+10.2%	-7.0%
Sep 22, 2023	Rowland Lloyd A50	General Counsel	Sell	5,486	$1.30	$7,135.09	-6.4%	+10.2%	-7.0%
Mar 29, 2023	Jones Elaine V	Director	Buy	5,000	$1.55	$7,750.00	+3,521%	-8.1%	+42.0%
Mar 16, 2023	Ogden Christopher53	SVP, Finance and Accounting	Sell	516	$1.98	$1,021.32	-1.3%	-19.1%	+6.7%
Mar 16, 2023	McCarthy Sean A.68	CEO	Sell	7,121	$1.88	$13,391.04	-1.8%	-19.1%	+6.7%
Mar 16, 2023	Campoy Carlos	Chief Financial Officer	Sell	1,748	$1.98	$3,459.47	-4.4%	-19.1%	+6.7%
Mar 16, 2023	Rowland Lloyd A50	General Counsel	Sell	2,037	$1.98	$4,031.22	-2.8%	-19.1%	+6.7%
Mar 16, 2023	Landau Jeffrey B55	Chief Financial Officer	Sell	1,477	$1.98	$2,923.28	-2.1%	-19.1%	+6.7%